Sarah, who has achoondroplasia, enjoys the local swings (IMAGE)
Caption
Sarah, who has achoondroplasia, was the first Australian participant enrolled in the global phase 3 trial of vosoritide
Credit
MCRI
Usage Restrictions
Only to be used with this story
License
Licensed content